Abstract
Recent studies have demonstrated that tumor cells have hierarchical organization with cancer stem cells at the apex. Cancer stem cells, also termed cancer initiating cells, have self-renewal capacity and might not be sensitive to cytotoxic drugs. Thus, these cells may be responsible for the high frequency of relapse in many cancers, such as acute leukemias, brain and breast cancer. This chapter will approach the evidences of the presence of leukemia stem cells and the therapeutic perspectives to reach these cells.
Keywords: Cancer stem cells, Hematopoietic Stem Cell (HSC), Leukemia Stem Cells (LSCs), Primitive Hematopoietic Cell, Normal Hematopoiesis, AML, CML, Epithelial–Mesenchymal Transition (EMT), Osteopontin (OPN), Therapeutic Opportunities.
Related Journals
Current Dentistry
Current Traditional Medicine
Adolescent Psychiatry
New Emirates Medical Journal
Current Radiopharmaceuticals
Recent Patents on Anti-Cancer Drug Discovery
Current Medicinal Chemistry - Anti-Cancer Agents
Current Cancer Therapy Reviews
Clinical Cancer Drugs
Anti-Cancer Agents in Medicinal Chemistry
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents